Mode
Text Size
Log in / Sign up

One in Six Amputations Happen Without Key Imaging

Share
One in Six Amputations Happen Without Key Imaging
Photo by National Cancer Institute / Unsplash

The Hidden Detour Before Amputation

For years, doctors assumed most patients got full evaluations before amputation. After all, restoring blood flow can save limbs. But recent data shows a stark gap. A new study of over 10,000 Medicare patients found one in six had no vascular imaging in the six months before surgery. That’s 16.6% with no scans to map their blood vessels. No chance to reroute circulation. Just an amputation, often avoidable.

This wasn’t random. Patients most likely to miss imaging had dementia, paralysis, or relied on Medicaid and Medicare (dual eligibility). They were more likely to face social barriers—no transportation, no caregiver support, lower health engagement. Surprisingly, it wasn’t the sickest medically. Those with the highest number of chronic conditions were more likely to get imaging. The system failed those who struggled to navigate it, not those with the most complex diseases.

Why Some Patients Vanish From the System

Think of blood vessels like highways to the legs. When traffic slows or stops, tissue starves. Revascularization is like clearing a roadblock—using stents or bypass surgery to restore flow. But you can’t fix what you haven’t mapped. Imaging is the GPS. Without it, surgeons operate blind.

Yet for many, the journey stops short. A patient with dementia may not report pain early. A paralyzed person might not reach a specialist’s office. Social disadvantage adds friction. Miss one appointment, lose insurance paperwork, lack a phone for follow-up calls—and the system moves on. These patients don’t get forgotten on purpose. They fall through cracks built into care pathways.

The study looked at Medicare data from 2021 to 2022. All patients had their first major amputation due to CLTI. Researchers checked claims for vascular specialist visits, imaging (like CT or ultrasound), and any revascularization attempts in the 180 days before hospitalization. They grouped patients into four paths. Only 32.7% had revascularization tried. Half had imaging but no procedure. And 9.4% had nothing—no specialist, no scan, no attempt.

One in Six Got No Scan

The most striking finding? Patients who skipped imaging had better short-term outcomes. They were less likely to be readmitted within 90 days. Their one-year survival was higher—40% died, compared to 51% in the revascularization group. At first glance, this seems to suggest skipping care works. But that’s misleading.

Here’s the catch. These patients were less likely to be aggressively treated not because they were too sick—but because they were overlooked. Their lower hospital use reflects disengagement, not better health. They weren’t dying from amputation complications. They were dying sooner from other causes, unseen and unsupported.

This doesn't mean this treatment is available yet.

Experts say the real issue is equity. The study found huge regional differences. In Boston and Atlanta, only 3% of patients had no imaging. In Little Rock, it was 16%. This kind of variation points to hospital-level policies, not patient choice. Some centers have care teams that automatically refer CLTI patients. Others don’t. Fixing this isn’t about new drugs or devices. It’s about systems.

So what should patients and families do? If leg pain persists, especially at rest or at night, ask for a vascular referral. Request imaging. Know that amputation is not the first step—it should be the last. For those with cognitive or mobility challenges, caregivers must advocate early. Bring up blood flow. Ask, “Have we tried to save the limb?”

The study has limits. It only looked at Medicare patients over 66. Results may differ for younger or privately insured people. It used claims data, so some care might have been missed in records. And it can’t prove why patients skipped steps—only that they did.

What happens next? Researchers urge hospitals to audit their own referral patterns. Simple changes—automated alerts, care coordinators, community outreach—could close gaps. Clinical trials are not needed. This is about applying known guidelines more fairly. For patients like James, that could mean the difference between keeping a limb and losing it. The tools exist. Now, the system must deliver them.

Share